Check the pharmacy 930,000 times the State Drug Administration informed.

▍ source: Seiber Blue - Pharmacy Manager▍ finishing: therecently, the State Drug Administration on the 2019 national drug regulatory departments at all levels of the investigation and sale of counterfeit and inferior drugs, 2019 national drug supervision departments at all levels in accordance with the "four most stringent" requirements of drug safety, organized to carry out supervision and inspection of pharmaceutical production and operation enterprises, to crack down on the production and sale of counterfeit and inferior drugs illegal actsAccording to the circular, a total of 22,342 drug production enterprises were inspected in 2019, 35,746 pharmaceutical wholesale enterprises, 937,648 pharmaceutical retail enterprises, and 1,394 were ordered to stop production and closein the inspection, a total of 77093 cases of violations of drug laws and regulations, a total of 50,729,000 yuan, of which 95 cases of the production of counterfeit drugs, 129 cases of counterfeit drugs, 1099 cases of sales of counterfeit drugs 1210 cases were treated according to the theory of counterfeit drugs, 442 cases of inferior drugs were produced, 593 cases were treated according to the theory of inferior drugs, 4372 cases of sale of inferior drugs were sold, and 6101 cases were cases of inferior drugsThree drug production licenses were revoked and 118 drug licenses were revokeda year has passed, although the drug production, operation, retail enterprises have changed the focus of inspection, but the production and sale of fake leave is still the focusaccording to the state market general office documents, this year's inspection will focus on the outbreak of protective suppliesOn May 11 this year, the State Administration of Markets and seven other departments jointly issued the National Action Plan for the Special Remediation of product quality and market order of epidemic prevention materials (hereinafter referred to as the "Programme")in accordance with the Program, this year all departments should focus on masks, protective clothing, ventilators, infrared thermometers (the amount of temperature gun), new coronavirus detection reagents and other five types of epidemic prevention materials and their important primary and secondary materials to strengthen supervision, to ensure the smooth operation of the whole industrial chain of epidemic prevention materialsat the same time, the Program emphasizes that the rectification should run through the whole chain of production, circulation and consumption of epidemic prevention materialsStrengthen the control of production source, strict enterprise qualification, clear product standards, improve product quality, strengthen the supervision of the circulation link, carry out the whole process traceability of non-conforming products, investigate the responsibility of production operators in accordance with the law, strengthen the supervision of the consumer market, and safeguard the interests of consumersfrom the point of view of illegal acts, this year focused on three major acts: first, in the product adulteration, falsely falsely charged, second-best or unqualified products posing as qualified products, production and sales of expired products, production and sales of no production date, no factory site, no product quality certificate and other "three no" products and other quality violations;, it is important to note that under the requirements of the new version of the Drug Administration Law, the penalties for counterfeiting are now more stringentSo, how to distinguish and punish the production and sale of counterfeit drugs?in accordance with the relevant provisions of the new version of the Drug Administration Law, the production (including preparation, the same below), the sale and use of counterfeit drugs, the use of inferior drugsIt is prohibited to produce or import pharmaceutical drugs without obtaining the supporting documents for drug approval, and to prohibit the production of raw materials, packaging materials and containers that have not been reviewed and approved in accordance with the provisions one of the following circumstances, it is a counterfeit drug: 1, the ingredients contained in the drug are not in conformity with the ingredients stipulated in the national drug standards; 2, posing as a drug with a non-drug or posing as another drug; 3, a metamorphosis of the drug; 4, the drug indicated by the indications or functional treatment beyond the prescribed scope , if there are any of the following cases, the content of the ingredients of the drug does not meet the national drug standards; 2, the contaminated drug; 3, the drug without marking or changing the validity period; 4, the drug that does not indicate or change the product batch number; 5, the drug that exceeds the validity period; 6, the drug that adds preservatives, accessories without authorization; 7, other drugs that do not meet the drug standard , for the production and sale of counterfeit drugs, confiscation of illegal production and sale of drugs and illegal proceeds, ordered to stop production and stop business for rectification, revocation of drug approval documents, and the illegal production and sale of drugs worth less than 15 times 30 times the value of the fine; for the production or sale of inferior drugs, confiscate illegally produced or sold drugs and illegal income, and impose a fine of ten times or less than 20 times the value of illegally produced or sold drugs; If the production and sale of Chinese medicine tablets does not meet the standards of the drug and does not affect the safety and effectiveness, the order shall be given a correction within a time limit and a warning shall be given; at the same time, the production and sale of counterfeit drugs, or the production and sale of inferior drugs and serious circumstances, the legal representative, the principal person in charge, the person directly responsible and other responsible personnel, confiscation of the income earned from the unit during the period of the occurrence of the illegal act, and the amount of income obtained by less than 30 percent of the fine, life ban from engaging in drug production and operation activities, and may be subject to detention by the public security organs for not more than five days to 15 days The raw materials, accessories, packaging materials and production equipment used exclusively by the producers for the production of counterfeit and inferior drugs shall be confiscated.